To address these issues, recent efforts have been devoted to developing nanocarriers that can efficiently deliver multiple therapeutics with controlled release properties and increased tumor deposition.
Although no FDA-approved therapies currently exist for the Notch pathway, multiple therapeutics (e.g., demcizumab, tarextumab, GSI MK-0752, R04929097, and PF63084014) have been developed to target different aspects of this pathway for both hematologic and solid malignancies.
In developing new generations of coatings for medical devices and tissue engineering scaffolds, there is a need for thin coatings that provide controlled sequential release of multiple therapeutics while providing a tunable approach to time dependence and the potential for sequential or staged release.
Multiple therapeutics, including drugs, anti-inflammatory interleukin-10 gene therapy, antibiotics, and mesenchyme stromal cells, have been tested for efficacy in EVLP [32 35].
The general strategy presented herein can potentially be utilized for the preparation of polymeric vehicles that are capable of delivering multiple therapeutics under controlled individual release kinetics.
Lastly, multiple therapeutics that target FLT3 receptor (e.g., CEP701, PKC412, AB220) are in development for the treatment of AML.
10, 11 At present, no treatment is approved for FRDA, but multiple therapeutics in development may increase levels of frataxin.
This chapter provides an overview of major historical developments in multiple sclerosis (MS) therapeutics and changing concepts of MS, and also emphasizes on the interdependence between these two lines of work.
This connection was a demonstration of the multiple pathways and diversity of targeted therapeutics and an advocate for laboratory research in understanding the most beneficial treatments for individuals.
Providing essential principles of herbs including diet and energy; teaching the principles of disease and diagnosis within multiple frameworks of medical systems; teaching herbal preparation, therapeutics and formula.
